Future of Molecular Medicine

描述(由申请人提供)： 第三次分类研讨会由首席调查员和Dr。 Jean-Luc Urbain将于2001年6月23日星期六在安大略省多伦多举行， 在核医学学会年会开始的前一天再次召开 开会。发言人的完整名单尚未敲定。主 这次研讨会的目的是教育核医学界 将主导药物的分子医学的最新进展 新千年的发展，并可能影响到 放射性药物的开发也是如此。国际基因组学专家， 蛋白质组学、药物基因组学和DNA疗法将为参与者提供 这些新技术的尖端技术。详细描述了 这些技术的分子生物学将介绍每一门学科。我们也 相信参与者与这些科学家的互动提供了一种 将我们的社区与分子生物学世界联系起来的独特机会 这将影响未来的核医学实践。 具体地说，本系列研讨会的目的是使与会者能够： 1)了解基因测序、聚合酶链式反应、克隆 反义和基因治疗。 2)认识到人类基因组计划在医学上的影响，并 其他基因组学。 3)讨论了蛋白质组学的重要性和现有的结构分析方法。 分析。 4)了解药物反应中潜在的遗传原因。 5)找出反义化疗的优点和缺点 疾病的治疗。 6)认识基因治疗在疾病治疗中的潜在作用。

DESCRIPTION (provided by applicant): The third categorical seminar hosted by the Principal Investigator and Dr. Jean-Luc Urbain will be held in Toronto, Ontario on Saturday 23 June, 2001, again one day before the beginning of the Society of Nuclear Medicine Annual Meeting. A complete list of speakers has not yet been finalized. The main objective of this seminar is to educate the nuclear medicine community on those recent developments in molecular medicine which will dominate drug development in the new millennium and which are likely to influence radiopharmaceutical development as well. International experts in genomics, proteomics, pharmacogenomics and DNA therapies will provide participants with the state-of-the-art of these new technologies. A detailed description of the molecular biology of these technologies will introduce each subject. We also believe that the interaction of participants with these scientists provides a unique opportunity to bridge our community with the world of molecular biology that will impact tomorrow's nuclear medicine practice. Specifically, the aim of this seminar series was to enable the attendees to: 1) Understand the molecular biology of gene sequencing, PCR, cloning, antisense and gene therapy. 2) Recognize the implications in medicine of the human genome project and other genomics. 3) Discuss the importance of proteomics and the current methods of structural analysis. 4) Appreciate the genetic causes underlying variability in response to drugs. 5) Identify the strengths and weaknesses of antisense chemotherapy for the treatment of diseases. 6) Recognize the potential role of disease treatment by gene therapy.